Andrew Keith is an associate in the Patent Counseling & Prosecution practice group and a member of the Cooley Litigation department. He joined the Firm in 2011 and is a resident in the Washington, DC office.
Mr. Keith specializes in the areas of patent preparation and prosecution, particularly in the biotech, and pharmaceutical fields. Specifically, Mr. Keith has experience in patent preparation and prosecution of pharmaceutical formulations, small molecules and biomolecule therapeutics. Mr. Keith also has experience in matters involving patent litigation and drafting non-infringement, infringement, invalidity and patentability opinions.
Prior to joining the Firm, Mr. Keith was a patent attorney at Sheppard Mullin Richter & Hampton LLP in that firm's Washington DC office. Before entering law school, Mr. Keith worked for over seven years performing research and development in both the biotech and pharmaceutical fields.
Mr. Keith received his JD, cum laude, from American University Washington College of Law in 2008. He received his Masters in Science in Chemistry, with an emphasis in Organic chemistry from the University of Miami in 2005. Specifically, Mr. Keith worked on modifying drug target kinase enzymes for NMR and kinetic studies. Prior to graduate school, Mr. Keith was a Research Associate at Thermo Biostar, researching and developing rapid diagnostic products for infectious diseases. Mr. Keith received his BA in Biochemistry and in Molecular, Cellular and Development Biology from the University of Colorado in 1999.
- American University, Washington College of Law
JD, 2008, cum laude
- University of Miami
- University of Colorado at Boulder
- District of Columbia
- Registered to practice before the United States Patent & Trademark Office (USPTO)